Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses.

JSON

Sheward DJ, Yang Y, Westerberg M, Öling S, Muschiol S, Sato K, Peacock TP, Karlsson Hedestam GB, Albert J, Murrell B

Lancet Infect Dis 23 (11) e462-e463 [2023-11-00; online 2023-09-27]

Clinical Genomics Stockholm [Service]

PubMed 37776877

DOI 10.1016/S1473-3099(23)00588-1

Crossref 10.1016/S1473-3099(23)00588-1

pii: S1473-3099(23)00588-1